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ABSTRACT. Twenty new isatin-3-[N2-(benzimidazol-1-acetyl)]hydrazones (IV) were synthesized from ten 
different isatin-3-[N2–(chloroacetyl)] hydrazones (III) by reacting with benzimidazole and 2-methyl 
benzimidazole. The intermediates were obtained from isatin hydrazones (II) on condensation with chloroacetyl 
chloride. These compounds were characterized by IR, 1H NMR and mass spectra. All the compounds were 
screened for antimicrobial, antioxidant and cytotoxic activity. Some of the new compounds showed promising 
antibacterial and antifungal activity. 
  




In recent years, several benzimidazole derivatives have been synthesized and reported to possess 
varied biological and pharmacological properties. Benzimidazole nucleus is one of the bioactive 
heterocyclic compounds that exhibit a range of biological activities. The pharmacological 
activities of the benzimidazole containing moiety have been well documented. It is reported that 
benzimidazole derivatives were active against Staphylococcus aureus, Escherichia coli, and 
Candida albicans [1]. Anthelmintic activities of few synthesized benzimidazole derivatives 
were also reported [2]. Further, in-vitro antiprotozoal activity of synthesized N-azopridinium 
salts and several betaines were reported adding to the existing pool of biological effects. Few 
other observations can be made from the available literature, that the benzimidazole molecule 
posses different biological activities such as antihistaminic activity [4], antitumor activity [5], 
cytotoxic activity [6], antitubercular activity [7], antifungal [8], antiviral [9] and anti-
inflammatory [10] activities.  
An interesting observation one could make from a careful survey of the literature is the 
absence of any report on isatin derivatives containing benzimidazole system in the side chain at 
3rd position. So, it has been felt worthwhile to undertake the present work of synthesizing such 
compounds for the first time by appropriate synthetic routes, with a view to evaluate for 
antibacterial, antioxidant and anticancer activities. The required isatins (I) and their hydrazones 
(II) were prepared by the standard methods available in literature. Isatin hydrazones on 
treatment with chloroacetylchloride afforded their respective isatin-3-[N2-(chloro acetyl)] 
hydrazones (III). Each of these compounds were reacted with benzimidazole and 2-methyl 
benzimidazole in presence of dry acetone with an anhydrous potassium carbonate to get the 
respective isatin-3-[N2-(benzimidazol/2-methylbenzimidazol-1-acetyl)]hydrazones (IV). The 
intermediates and the title compounds were purified by recrystallization and characterized by 
analytical and spectral (IR, NMR and mass) data. 
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Materials and instruments 
 
All the chemicals were of synthetic grade and commercially procured from Sigma Aldrich, 
Mumbai, India. The melting points were determined by open capillary method and were 
uncorrected. Infrared spectra were recorded on FTIR (Bruker Alpha-E) by KBr disc method. 1H 
NMR spectra were recorded at 400MHz in CDCl3 as solvent and TMS as an internal standard 
using Bruker Advance 400 instrument. In addition, mass spectra were recorded on PEP-SCIUX-
APIQ pulsar mass spectrophotometer. Elemental analysis was performed on Perkin-Elmer 
EAL240 elemental analyzer. 
 
Synthesis of compounds 
 
Synthesis of isatin hydrazones (II). An appropriate isatin (indole-2,3-dione) (I, 0.01 mol) was 
dissolved in alcohol (20 mL) and added hydrazine hydrate (99%, 0.015 mol) while shaking. The 
reaction mixture was stirred well, warmed on a water-bath for 10 min and left in the refrigerator 
for 3 hours. The resultant yellow crystalline solid was filtered, washed repeatedly with small 
portions of cold water and finally with a small quantity of cold alcohol. The product was dried 
and purified by recrystallization from chloroform. The compounds thus obtained were 
characterized by comparison with their physical constants reported in the literature. 
 
Synthesis of isatin-3-[N2-(chloroacetyl)] hydrazones (III). An appropriate isatin hydrazone (II, 
0.01 mol) was heated under reflux with chloroacetyl chloride (0.01 mol) in dry benzene under 
anhydrous conditions using calcium chloride guard-tube for 2 hours. The product thus formed 
was filtered and washed with small portions of benzene to remove the un-reacted chloroacetyl 
chloride.  It was purified by recrystallization from suitable solvent(s). 
 
Synthesis of benzimidazole. O-phenylenediamine of weight 27 g (0.25 mol) is placed in a 250 
mL round bottomed flask and added 17.5 g (16 mL, 0.34 mol) of formic acid (90%). The 
reaction mixture was refluxed on a water bath for 2 hours, cooled, then added 10 percent sodium 
hydroxide solution slowly, with constant rotation of the flask, until the mixture was just alkaline 
to litmus. Later, filter off the crude benzimidazole at the pump, washed with ice-cold water 
thoroughly. It was completely dried and purified by recrystallization from boiling water. The 
yield of pure benzimidazole, m.p. 171 oC (lit. 172 oC), is 25 g (85%). Adopting this procedure, 
2-methylbenzimidazole was also prepared by the reaction of O-phenylenediamine and acetic 
acid. It was recrystallized from 10% aqueous ethanol, the yield is 2.2 g (56%), m.p. 176 oC (lit. 
176 oC). 
 
Synthesis of isatin-3-[N2-(benzimidazol/2-methylbenzimidazol-1-acetyl)]hydrazone (IV). A 
mixture of an appropriate isatin-3-[N2-(chloroacetyl)]hydrazone (III, 0.01 mol) and a 
benzimidazole (0.01 mol) or 2-methyl benzimidazole (0.01 mol) in dry acetone (20 mL) and 
anhydrous potassium carbonate, heated under reflux on a water bath for 5 h. The solvent was 
evaporated and poured in crushed ice. The product thus formed was filtered, washed with cold 




All the compounds were screened for antibacterial, antifungal, antioxidant and cytotoxic activity 
by following the standard protocols as available in the literature. 
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Antibacterial activity. The antibacterial activity of synthesized compounds was conducted 
against two gram positive bacteria viz., Bacillus subtilis and Staphylococcus aureus and two 
gram negative bacteria viz., Escherichia coli and Proteus vulgaris by using cup plate method. 
Ampicillin sodium was employed as standard to compare the results. Both the test and standard 
compounds were studied at 10 µg/mL/cup. 
 
Antifungal  activity. All those compounds screened for antibacterial activity were also tested for 
their antifungal activity by using potato-dextrose-agar medium against clotrimazole as standard. 
Both the test and standard compounds were studied at the same dose of 10 µg/mL.  The fungi 
employed for screening were: Aspergillus niger and Cunninghamella verticulata. 
 
Antioxidant activity. The model of scavenging the stable DPPH (1,1-diphenyl-2-picryl-hydrazil) 
radical is a widely used method to evaluate antioxidant activities in a relatively shorter time 
compared with other methods. The effect of antioxidants on DPPH radical scavenging was 
thought to be owing to their hydrogen donating ability. The reduction in absorbance is 




Test of Absorbance -Blank  of Absorbance
Inhibition %   
 
Cytotoxic activity. Cytotoxic activity was performed on against HBL-100 cell lines and HeLa 
cell lines using Microculture tetrazolium assay (MTT) method. It is based on the metabolic 
reduction of 3-(4,5-dimethylthiazol-2,5-diphenyl) tetrazolium bromide (MTT) to water insoluble 
formazan crystals with mitochondrial dehydrogenase enzyme, which gives direct correlation of 
viable cells. 
The reaction sequence used in the synthesis of isatin-3-[N2-(benzimidazol/2-methyl 
benzimidazol-1-acetyl)]hydrazone (IV) is depicted in the Scheme 1. The required isatin-3-[N2-
(chloroacetyl)] hydrazones (III) have been prepared by a reaction of respective isatin 
hydrazones with chloroacetyl chloride. The isatin hydrazones (II) on the other hand, have been 
obtained by the reaction of respective isatins (I) with hydrazine hydrate (99%). These 
compounds (XVI) have been purified by recrystallization from suitable solvent(s) and 
characterized by their analytical and spectral data.  
The IR spectrum of the isatin-3-[N2-(chloroacetyl)]hydrazone (III, R1 = H) exhibited the 
absorption frequencies (in cm-1) at: 3238 (NH), 1700 (C=O, lactam), 1666 (C=O, acid 
hydrazide), 1624 (C=C, aromatic), 1533 (C=N), 951 (C=C, aromatic). Each of the isatin-3-[N2-
(chloroacetyl)]hydrazones (XVI) has been subjected to a nucleophilic substitution reaction with 
benzimidazole and 2-methyl benzimidazole in dry acetone and anhydrous potassium carbonate 
to get their respective isatin-3[N2-(benzimidazol/2-methylbenzimidazol-1acetyl)]hydrazone 
(IV); similarly twenty compounds were prepared. The resultant products have been purified by 
recrystallization from suitable solvents and characterized by their physical data (Table 1) and 
spectral (IR, NMR and mass) data as follows: 
  
Iva. Yield 85%, mp 262 ᵒC; IR(KBr) cm-1: 3422(-NH str), 1696 (C=Ostr, lactam), 1625 (C=O, 
acid hydrazine), 1502 (C=Nstr); 1HNMR (δppm): 12.71 (s, 1H, lactam), 11.35 (s, 1H, NHCO), 
8.33 (s, 1H, -N-CH-N), 6.97-8.27 (m, 8H, Ar-H), 5.82 (s, 2H, COCH2); EI-MS: 319(M
+). 
 
IVb. Yield 80%, mp 241 ᵒC; IR (KBr) cm-1: 3422 (-NH str), 1696 (C=Ostr, lactam), 1625 (C=O, 
acid hydrazine), 1502 (C=Nstr); 1HNMR (δppm): 12.69 (s, 1H, lactam), 11.21 (s, 1H, NHCO), 
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Scheme 1. Synthesis of isatin-3-[N2-(benzimidazol/2-methylbenzimidazol-1-cetyl)]hydrazone 
(IV), IVa-t R1 = H, 5-CH3, 5-Cl, 5-Br, 5-NO2, 5-SO2NO2, 5-COOH, 5-COOCH3, 6-
Br, 7-CH3; R2 = H, CH3. Reagents and conditions: 1) isatin (I, 0.01 mol), ethanol, 
hydrazine hydrate (99%, 0.015 mol), Δ10 min, 2) chloroacetyl chloride (0.01 mol), 
dry benzene, reflux 2h and 3) benzimdazole or 2-methyl benzimidazole (0.01mol), 
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IVc. Yield 78%, mp 212 ᵒC; IR (KBr) cm-1: 3410 (-NH str), 1690 (C=Ostr, lactam), 1610 (C=O, 
acid hydrazine), 1480 (C=Nstr); 1HNMR (δppm): 12.69 (s, 1H, lactam), 11.21 (s, 1H, NHCO), 
8.22 (s, 1H, -N-CH-N), 6.80-8.17 (m, 8H, Ar-H), 5.71 (s, 2H, COCH2); EI-MS: 353 (M
+). 
 
IVd. Yield 64%, mp 279 ᵒC; IR (KBr) cm-1: 3435 (-NH str), 1710 (C=Ostr, lactam), 1640 (C=O, 
acid hydrazine), 1515 (C=Nstr); 1HNMR (δppm): 12.85 (s, 1H, lactam), 11.40 (s, 1H, NHCO), 
8.50 (s, 1H, -N-CH-N), 6.98-8.30 (m, 8H, Ar-H), 5.90 (s, 2H, COCH2); EI-MS: 398 (M
+). 
 
IVe. Yield 88%, mp 219 ᵒC; IR (KBr) cm-1: 3405 (-NH str), 1680 (C=Ostr, lactam), 1605 (C=O, 
acid hydrazine), 1475 (C=Nstr); 1HNMR (δppm): 12.65 (s, 1H, lactam), 11.15 (s, 1H, NHCO), 





Antibacterial activity. The antibacterial activity data of isatin-3-[N2-(benzimidazol/2-methyl 
benzimidazol-1-acetyl)] hydrazones (IV, Table 2) indicates that the compounds have a 
noticeable degree of inhibition, specifically against gram-positive strain, i.e. B. subtilis. Most 
significant of them has been found to be the compound IVa showed greater inhibitory effect 
against the organisms employed, particularly against B. subtilis and S. aureus with the zones of 
inhibition of 22 and 20 mm, respectively, which has been comparable to that of the standard 
employed at the concentration of 10 g/mL. This has been closely followed by compound IVd 
with a 5-bromo substituent in indolinone which showed significant inhibitory effect specifically 
against B. subtilis and E. coli with zones of inhibition of 18 mm, each. Some of the compounds 
showed moderate antibacterial activity against both the gram-negative organisms E. coli and P. 
vulgaris. The compounds with 5-carboxylic acid and 5-carbomethoxy substituents on indolinone 
have not exhibited any activity against gram-negative organisms. Recently, Guo et al. [11] has 
excellently reviewed antibacterial potential of isatin derivatives. Intriguingly, azo linked 
substituted benzimidazole, benzoxazole, and benzothiazole synthesized by Mishra et al. [12] 
through diazo coupling also exhibited in vitro antibacterial activity against Staphylococcus 
aureus and Escherichia Coli strains. Mannich bases of benzimidazole derivatives have also 
shown in vitro antibacterial activity against Bacillus subtilis, Bacillus pumilus, Escherichia coli 
and Pseudomonas aeruginosa organisms [13].  
 
Antifungal activity. The antifungal activity data of isatin-3-[N2-(benzimidazol/2-
methylbenzimidazol-1-acetyl)]hydrazones (IV) as depicted in Table 2 shows that the 
compounds of this series have shown antifungal action against A. niger and C. verticulata 
except compounds IVh, IVq and IVr, of course, with a degree of variation in their action. 
Compounds IVc (R1 = 5-Cl, R2 = H) and IVm (R1 = 5-Cl, R2 = CH3) have more activity against 
C. verticulata with the zones of inhibition of 17 mm and 16 mm respectively among all the test 
compounds. The data shows that this series of compounds have been found to be comparatively 
more effective among all the series tested for antifungal activity. In an interesting work reported 
by Jarrahpour et al. [14], twelve new bis-Schiff bases of isatin, benzylisatin and 5-fluoroisatin 
3a-3l were prepared by condensation of isatin, benzylisatin and 5-fluoroisatin with primary 
aromatic amines. Though these compounds exhibited antiviral and anticancer activity, the 
candidates failed to show antifungal activity when tested against S. cerevisiae (ATCC 28383) or 
C. albicans (CIP 1180-79). However, Kaplancıklı et al. [15] reported few benzimidazole-
thiazole derivatives with proven anticandidal activity. Several bisbenzimidazole compounds 
exhibited moderate to excellent antifungal activities against fungal strains, with MIC values 
ranging from 15.6 to 0.975 μg/mL and the antifungal activity were found to depend on alkyl 
chain length [16]. 
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Antioxidant activity. The IC50 values of antioxidant activity of isatin-3-[N
2-(benzimidazol/2-
methylbenzimidazol-1acetyl)]hydrazone derivatives (IV) are in the range of 10.45 to 17.56 M 
as shown in Table 3. The compound IVa (R1 = R2 = H) has shown highest percentage of free 
radical scavenging activity at a concentration of 10.45 M among these compounds. This has 
been followed by the compounds IVc, IVd and IVn with an IC50 of 10.52, 10.61 and 10.98 M, 
respectively. In an attempt to synthesize gastro-sparing antiinflammatory agents, Sharma et al. 
[17] has reported antioxidant activity of 5-methanesulphonamido benzimidazole derivatives.  
Other benzimidazole derivatives has also shown remarkable in vitro antioxidant activity [18-20]. 
  
Cytotoxic activity. IC50 values of cytotoxic activity of isatin-3-[N
2-(benzemidazol/2-
methylbenzimidazol-1-acetyl)]hydrazone (IV) are given the Table 3. They are ranging from 
345.59 to 473.9 M.  The compound IVm (R1 = 5-Br, R2 = CH3) has shown highest cytotoxic 
activity among the series at a concentration of 345.59 M against HeLa cell lines. This has been 
followed by the compound IVd (R1 = 5-Br, R2= H) with IC50 of 347.69 M against HBL-100 
cell lines.  The compounds IVe, IVg, IVh, IVp, IVq, IVr and IVt have not shown any activity 
against HBL-100 cell lines and HeLa cell lines. Recent literature also revealed potential 
cytotoxic activity of several benzimidazole derivatives [21, 22] 
 
Table 1.Physical data of isatin-3-[N2-(benzimidazol/2-methylbenzimidazol-1-acetyl)]hydrazone (IV). 
 
S. No. Compd. R1 R2 Mol. Formula m.p. (◦C) Yield (%) 
1 IV a H H C17H13N5O2 262 85 
2 IV b 5-CH3 H C18H15N5O2 241 80 
3 IV c 5-Cl H C17H12N5O2Cl 212 78 
4 IV d 5-Br H C17H12N5O2Br 279 64 
5 IV e 5-NO2 H C17H12N6O4 210 88 
6 IV f 5-SO2NH2 H C17H14N6O4S 272 70 
7 IV g 5-COOH H C18H13N5O4 222 60 
8 IV h 5-COOCH3 H C19H15N5O4 229 65 
9 IV i 6-Br H C17H12N5O2Br 248 84 
10 IV j 7-CH3 H C18H15N5O2 238 82 
11 IV k H CH3 C18H15N5O2 259 80 
12 IV l 5-CH3 CH3 C19H17N5O2 245 82 
13 IV m 5-Cl CH3 C18H14N5O2Cl 240 75 
14 IV n 5-Br CH3 C18H14N5O2Br 265 65 
15 IV o 5-NO2 CH3 C18H14N6O4 205 75 
16 IV p 5-SO2NH2 CH3 C18H16N0O4S 276 72 
17 IV q 5-COOH CH3 C19H15N5O4 210 65 
18 IV r 5-COOCH3 CH3 C20H17N5O4 232 68 
19 IV s 6-Br CH3 C18H14N5O2Br 228 75 
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Table 2. Antibacterial activity and antifungal of isatin-3-[N2-(benzimidazol/2-methylbenzimidazol-1-
acetyl)]hydrazone (IV). 
 
S. No. Compd.                  R1 R2 
Zone of inhibition (in mm) 
Bacterial species Fungal species 
B. subtilis S. aureus E. coli P. vulgaris A. niger C. verticulata 
1 IV a H H 22 20 18 17 15 14 
2 IV b 5-CH3 H 15 13 12 11 12 13 
3 IV c 5-Cl H 16 15 14 12 13 17 
4 IV d 5-Br H 18 17 18 16 10 14 
5 IV e 5-NO2 H 13 11 -- -- 8 10 
6 IV f 5-SO2NH2 H 13 12 11 -- 10 12 
7 IV g 5-COOH H 11 -- -- -- 8 6 
8 IV h 5-COOCH3 H 13 -- -- -- -- -- 
9 IV i 6-Br H 17 16 15 13 9 12 
10 IV j 7-CH3 H 16 15 -- -- 10 8 
11 IV k H CH3 18 17 16 15 14 12 
12 IV l 5-CH3 CH3 16 15 -- -- 11 12 
13 IV m 5-Cl CH3 16 15 14 13 14 16 
14 IV n 5-Br CH3 18 16 17 15 12 13 
15 IV o 5-NO2 CH3 13 12 14 13 10 7 
16 IV p 5-SO2NH2 CH3 15 16 -- -- 11 7 
17 IV q 5-COOH CH3 12 -- -- -- -- -- 
18 IV r 5-COOCH3 CH3 14 12 -- -- -- -- 
19 IV s 6-Br CH3 17 16 16 14 10 11 
20 IV t 7-CH3 CH3 18 15 16 15 11 7 
21 Ampicillin (10 μg/cup) 22 20 18 17 -- -- 
22 Clotrimazole (10 μg/cup) -- -- -- -- 19 20 
 
Table 3. Antioxidant activity and cytotoxic activity of isatin-3-[N2-(benzimidazol/2-methylbenzimidazol-1-
acetyl)]hydrazone (IV). 
 
S. No.    Compd.          R1             R2 
Antioxidant activity Cytotoxic activity 
IC50 value (µM) 
HBL-100 cell lines 
IC50 values (µM) 
HeLa cell lines 
IC50 values (µM) 
1 IV a H H 10.45 433.13 411.84 
2 IV b 5-CH3 H 15.07 441.86 NA 
3 IV c 5-Cl H 10.52 365.28 349.84 
4 IV d 5-Br H 10.61 347.69 325.46 
5 IV e 5-NO2 H 13.39 NA NA 
6 IV f 5-SO2NH2 H 15.6 NA NA 
7 IV g 5-COOH H 16.61 NA NA 
8 IV h 5-COOCH3 H 17.56 NA NA 
9 IV i 6-Br H 11.43 367.15 373.99 
10 IV j 7-CH3 H 14.91 473.9 NA 
11 IV k H CH3 11.63 454.48 463.36 
12 IV l 5-CH3 CH3 14.12 NA NA 
13 IV m 5-Cl CH3 11.39 375.59 345.59 
14 IV n 5-Br CH3 10.98 357.79 355.17 
15 IV o 5-NO2 CH3 14.37 401.58 NA 
16 IV p 5-SO2NH2 CH3 15.13 NA NA 
17 IV q 5-COOH CH3 16.92 NA NA 
18 IV r 5-COOCH3 CH3 17.43 NA NA 
19 IV s 6-Br CH3 13.67 391.56 365.49 
20 IV t 7-CH3 CH3 15.05 NA NA 
21 Ascorbic acid 5.87 -- -- 
22 Cisplatin -- 25.00 25.00 
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The synthesized novel isatin-3-[N2-(benzimidazol-1-acetyl)] hydrazones were found to possess 
remarkable biological activities. The compounds showed antibacterial activity against B. 
subtilis, S. aureus, E. Coli and P. vulgaris and antifungal activity against A. Niger and C. 
verticulata. The results were promising for antioxidant activity in free radical scavenging assay. 
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